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Objective: We sought to compare the results of ascending aorta–hemiarch replace-
ment by using 2 different methods of cerebral protection in terms of hospital
mortality, neurologic outcome, and systemic morbidity and to determine predictive
risk factors associated with hospital mortality and neurologic outcome after ascend-
ing aorta–hemiarch replacement.
Methods: Between January 1995 and September 2001, 289 patients (mean age,
62.2  13.2 years; urgent status, 122/289 [42.2%]) underwent ascending aorta–
hemiarch replacement with the aid of antegrade selective cerebral perfusion (161
patients) or deep hypothermic circulatory arrest (128 patients).
Results: Overall hospital mortality was 11.4% (deep hypothermic circulatory
arrest group, 13.3%; antegrade selective cerebral perfusion group, 9.9%; P 
.375). A logistic regression analysis revealed acute type A dissection (P  .001;
odds ratio, 4.3) and age of greater than 70 years (P  .019; odds ratio, 2.5) to
be independent predictors of hospital mortality. The permanent neurologic
dysfunction rate was 9.3% (deep hypothermic circulatory arrest group, 12.5%;
antegrade selective cerebral perfusion group, 7.6%; P  .075). Logistic regres-
sion analysis revealed acute type A dissection (P  .001; odds ratio, 6.7) and
history of cerebral infarction–transient ischemic attack (P  .038; odds ratio,
3.4) to be independent predictors of permanent neurologic dysfunction. The
transient neurologic dysfunction rate was 8.0% (deep hypothermic circulatory
arrest group, 7.1%; antegrade selective cerebral perfusion group, 8.7%; P 
.530). Acute type A dissection (P  .001; odds ratio, 5.1) was indicated as an
independent predictor of transient neurologic dysfunction by means of logistic
regression. Renal dysfunction (postoperative creatinine level of 250 mol/L;
deep hypothermic circulatory arrest, 10 [7.8%]; antegrade selective cerebral
perfusion, 6 [3.7%]; P  .030), as well as prolonged intubation time (deep
hypothermic circulatory arrest, 3.8  6.3 days; antegrade selective cerebral
perfusion, 2.2  2.5 days; P  .005) were more common in the deep hypo-
thermic circulatory arrest group.
Conclusion: The use of antegrade selective cerebral perfusion and deep hypothermic
circulatory arrest during ascending aorta–hemiarch replacement resulted in accept-
able hospital mortality and neurologic outcome. Reduced postoperative intubation
time and better renal function preservation were observed in the antegrade selective
cerebral perfusion group.
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Use of optimal methods of brain, spinal,and myocardial protection, as well as pre-vention and treatment of hemorrhage andcoagulopathy, are primary concerns dur-ing operations of the thoracic aorta.
Current methods of brain protection include deep hypo-
thermic circulatory arrest (DHCA), retrograde cerebral per-
fusion, and antegrade selective cerebral perfusion (ASCP).
All 3 methods have advantages and disadvantages.
In our institute ASCP is currently the method of choice
for cerebral protection, especially for patients requiring
complex aortic arch repairs. When a circulatory arrest time
of less than 30 minutes is anticipated, the selection of the
brain protection method (between DHCA and ASCP) de-
pends on the surgeon’s preference.
This study was undertaken to determine the predictive
risk factors associated with hospital mortality and neuro-
logic outcome in patients undergoing ascending aorta–
hemiarch replacement with ASCP and DHCA. A compari-
son between the 2 techniques was also performed in terms
of hospital mortality, neurologic outcome, and systemic
morbidity.
Patients and Methods
Between January 1995 and September 2001, 289 patients under-
went ascending aorta–hemiarch replacement at the St Antonius
Hospital, Department of Cardiothoracic Surgery, Nieuwegein, The
Netherlands.
Medical records were reviewed for clinical variables, including
preoperative status, intraoperative data, and early postoperative
complications (see Appendix). There were 189 (65.3%) men and
100 (34.7%) women, with a mean age of 62.2  13.2 years (age
range, 23-85 years). The indications for surgical intervention were
acute type A dissection in 122 (42.2%) patients and chronic
postdissection aneurysm or degenerative aneurysm in 167 (57.8%)
patients.
Cerebral protection was achieved by means of DHCA in 128
patients (DHCA group, 44.3%) and ASCP and moderate hypother-
mia in 161 patients (ASCP group, 55.7%). The year in which the
operation was performed did not influence the selection of the
brain preservation technique used. Patient demographics were
essentially similar in the 2 groups (Table 1).
All patients having elective surgery underwent preoperative
evaluation of cerebral circulation with Doppler ultrasonography of
the extracranial vessels, digital subtraction angiography of the
extracranial and intracranial circulation, carotid compression tests
with monitoring by means of electroencephalography to evaluate
occlusion intolerance, or a transcranial Doppler ultrasonographic
study when available.
Operative Technique
Induction of anesthesia was obtained with 2 mg/kg propofol, 2
g/kg fentanyl, and 0.1 mg/kg pancuronium. Anesthesia was
maintained with propofol and fentanyl. For all patients, pH balance
control was carried out by using the alpha-stat method. No phar-
macologic neuroprotective agents were administered. Aprotinin
was used sporadically.
Cerebral monitoring was achieved by means of a right radial
arterial pressure line, electroencephalography, regional oxygen
saturation in the bilateral frontal lobes with near-infrared spectros-
copy, and transcranial Doppler ultrasonographic measurement of
the blood velocity of the middle cerebral arteries.
The proximal thoracic aorta was approached by means of a
median sternotomy in all cases. After systemic heparinization,
cardiopulmonary bypass (CPB) was instituted with a cannula for
arterial return to the ascending aorta or the femoral artery and a
venous single 2-stage cannula in the right atrium. The left side of
the heart was vented through the right superior pulmonary vein.
Myocardial protection was achieved with cold crystalloid cardio-
plegia and topical pericardial cooling, maintaining the myocardial
temperature at or below 14°C.
In the DHCA group core cooling was instituted during CPB to
produce profound hypothermia. During this period, usually requir-
ing 30 to 40 minutes, the proximal repair was performed. The head
was packed in ice to prevent warming of the central nervous
system. When a flat-line electroencephalogram was achieved, cir-
culation was arrested, and the distal repair was carried out. On
completion of the procedure, gradual warming was carried out by
means of CPB, limiting the gradient between blood and body
temperature to less than 10°C, with a maximum blood temperature
of 37°C. A warming blanket was also used. Central warming was
usually discontinued at a rectal temperature of 35°C.
Details of our cannulation technique and method of ASCP with
moderate hypothermic circulatory arrest have been previously
described.1,2 Briefly, after CPB was instituted and the patients
were cooled to a nasopharyngeal temperature of 22°C to 26°C, the
systemic circulation was arrested, and the aneurysm was opened.
With the patient in the Trendelenburg position, 15F retrograde
coronary sinus perfusion cannulas (Medtronic DLP) connected to
the oxygenator with a separate single-roller pump head were
inserted into the innominate and left common carotid arteries
through the aortic lumen. The left subclavian artery was clamped
or occluded with a Fogarty catheter (Baxter Healthcare Corp) to
avoid the steal phenomenon.
Cerebral perfusion was initiated at a rate of 10
mLmin1kg1 and adjusted to maintain a right radial arterial
pressure of between 40 and 70 mm Hg.
During open distal anastomosis, blood perfusion to the lower
half of the body from the femoral artery, when cannulated, was
arrested or reduced to 500 mL/min.
The extent of the aortic replacement and the associated proce-
dures are listed in Table 2.
Statistical Analysis
Continuous variables were expressed as the mean  1 SD and
were analyzed by using the unpaired 2-tailed t test. Categoric
variables were presented as percentages and were analyzed with
the 2 test or Fisher exact test when appropriate. All preoperative
and intraoperative variables were first analyzed by using univariate
analysis to determine whether any single factor influenced hospital
mortality and neurologic outcome. Variables that achieved a P
value of less than .05 in the univariate analysis were examined by
using multivariate analysis with forward stepwise logistic regres-
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sion to evaluate independent risk factors for hospital mortality,
permanent neurologic dysfunction (PND), and transient neurologic
dysfunction (TND).
The analysis for PND (stroke or coma) and TND (postoperative
confusion, agitation, delirium, prolonged obtundation, or transient
parkinsonism with negative brain computed tomographic scanning
results and complete resolution before discharge) were conducted
separately. Risk factors for PND were examined in all patients who
survived the operation long enough to undergo neurologic evalu-
ation. Risk factors for TND were assessed in all operative survi-
vors without PND. Statistical analysis was performed with SASS
10.0 statistical software (SASS Inc).
Results
Hospital Mortality
Circulatory arrest and perfusion data are summarized in
Table 3.
There were 33 (11.4%) in-hospital deaths. Hospital mor-
tality for elective surgery was 5.8%, and that for urgent
surgery was 17.8% (P  .001). Causes of death were
multiorgan failure (n  14), PND (n  5), distal aneurysm
rupture (n  4), pneumonia (n  4), hemorrhage (n  2),
mediastinitis (n 2), low cardiac output (n 1), and bowel
ischemia (n  1).
Univariate analysis revealed that acute type A dissection
(P  .001), age greater than 70 years (P  .018), history of
cerebral infarction–transient ischemic attack (TIA; P 
.041), and Bentall procedure (P  .012) were significant
predictors of mortality. A stepwise logistic regression anal-
ysis showed that acute type A dissection (P  .001; odds
ratio [OR], 4.3; 95% confidence interval [CI], 1.90-9.67)
and age greater than 70 years (P  .019; OR, 2.5; 95% CI,
1.57-5.23) were independent predictors of hospital mortal-
ity.
Hospital Morbidity
PND occurred in 27 (9.3%) patients. Univariate analysis
revealed acute type A dissection (P  .001) and history of
cerebral infarction–TIA (P  .018) to be predictors of
stroke. These findings were confirmed by means of stepwise
logistic regression (acute type A dissection: P  .001; OR,
6.7; 95% CI, 2.44-18.41; history of cerebral infarction–TIA:
P  .038; OR, 3.4; 95% CI, 1.07-11.42).
TABLE 1. Patient demographics
Total group
(n  289), n
(%)
DHCA group
(n  128), n
(%)
ASCP group
(n  161), n
(%) P value
Male sex 189 (65.3) 81 (63.3) 108 (67.5) .454
Age (y) 62.2 13.2 63.0 61.5 .315
Acute type A dissection 122 (42.2) 58 (45.3) 64 (39.8) .342
History of hypertension 54 (18.7) 17 (13.3) 37 (23.0) .048
Diabetes 7 (2.4) 3 (2.3) 4 (2.4) .156
CAD 24 (8.3) 16 (12.5) 8 (5.5) .030
Creatinine 120 mol/L 26 (9.0) 11 (8.6) 15 (9.3) .223
History of CI-TIA 18 (6.2) 7 (5.5) 11 (6.8) .634
.218
EF  50% 264 (91.3) 114 (89.1) 150 (93.2)
30%  EF  50% 25 (8.7) 14 (10.9) 11 (6.8)
Previous cardiac operation 31 (10.7) 14 (10.9) 17 (10.6) .918
CAD, Coronary artery disease; CI, cerebral infarction; EF, ejection fraction.
TABLE 2. Extent of replacement and associated procedures
Total group,
n (%)
DHCA,
n (%)
ASCP,
n (%) P value
Extent of replacement .001
Ascending aorta 129 (44.6) 87 (68.0) 42 (26.1)
Hemiarch 160 (55.4) 41 (32.0) 119 (73.9)
Associated procedures (all combined) 152 (52.6) 64 (50) 88 (54.7) .431
AVR 24(8.3) 19 (14.8) 5 (3.1) .001
Bentall procedure 80 (27.7) 22 (17.2) 58 (36.0) .001
Aortic root remodeling 12 (9.5) 2 (1.6) 10 (6.2) .043
Aortic resuspension 12 (4.2) 3 (2.3) 9 (5.6) .169
Homograft 15 (5.2) 11 (8.6) 4 (2.5) .030
CABG 24 (8.3) 16 (12.5) 8 (5.0) .030
AVR, Aortic valve replacement; CABG, coronary artery bypass grafting.
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TND occurred in 21 (8.0%) of the 262 patients who
survived surgical intervention without PND. Univariate
analysis indicated that acute type A dissection (P  .002)
and ejection fraction of less than 50% (P  .048) were
significant predictors of TND. Concomitant procedures
(P  .066) and history of cerebral infarction–TIA (P 
.075) were of borderline significance. Stepwise logistic re-
gression showed acute type A dissection (P  .001; OR,
5.1; 95% CI, 1.87-14.19) to be an independent predictor of
TND.
Hospital morbidity included pulmonary complications
requiring mechanical ventilatory support for more than 5
days in 36 (12.5%) patients, renal failure requiring tempo-
rary hemodialysis in 5 (1.7%) patients, and postoperative
myocardial infarction (serum creatine phosphokinase level
of 300 IU/L with a creatine phosphokinase-MB fraction
of 3%) in 18 (6.2%) patients. Mean drain blood produc-
tion was 1524  1090 mL (range, 180-7200 mL). Thirty-
five (12.1%) patients underwent a repeat thoracotomy for
bleeding. Patients received an average of 5.3  4.2 units of
packed red cells (range, 0-25 units). The average blood
product consumption, defined as fresh frozen plasma and
platelet consumption, was 5.7 3.9 units per patient (range,
0-21 units). Univariate analysis revealed redo operations
(P  .026) and CPB time of greater than 240 minutes (P 
.012) to be risk factors for a greater consumption of packed
red cells and blood products.
DHCA Versus ASCP
The mean CPB times were similar in the DHCA and ASCP
groups (DHCA, 198  54 minutes; ASCP, 198  60
minutes; P  .982) as a result of prolonged myocardial
ischemic protection (DHCA, 105  41 minutes; ASCP,
129  48 minutes; P  .001) and total cerebral protection
(DHCA, 29  9 minutes; ASCP, 42  20 minutes; P 
.001) times in the ASCP group (Table 3). In fact, more
extended aortic tissue replacement and a larger number of
aortic root repairs were performed in the ASCP group
(Table 2).
Hospital mortality and morbidity of the 2 groups are
compared in Table 4.
Hospital mortality was 13.3% (17/128) in the DHCA
group and 9.9% (16/161) in the ASCP group (P  .375).
PNDs were more common in the DHCA group (16 [12.5%])
than in the ASCP group (11 [7.6%]), although statistical
significance was not reached (P  .075). TND occurred in
7.1% of the DHCA group and 8.7% of the ASCP group
(P  .530). Univariate analysis (Table 5) revealed that a
circulatory arrest time of greater than 25 minutes was asso-
ciated with an increased risk of TND in the DHCA group
(P  .021), whereas ASCP duration had no effect on
neurologic outcome.1 Renal dysfunction (postoperative cre-
atinine level of 250 mol/L; DHCA, 10 [7.8%]; ASCP, 6
[3.7%]; P  .030) and prolonged intubation time (DHCA,
3.8  6.3 days; ASCP, 2.2  2.5 days; P  .005) were
more common in the DHCA group. No differences were
observed between the 2 groups in terms of drain blood
production (P  .809) or packed red cells (P  .529) and
blood products consumption (P  .347).
Discussion
Despite the fact that the results of the surgical intervention
of the thoracic aorta have gradually improved, hospital
mortality and neurologic and systemic complications still
remain considerable. In our series hospital mortality was
11.4% (5.8% and 17.8% in elective and urgent procedures,
respectively).
Acute type A aortic dissection and advanced age were
independent predictors of hospital mortality, confirming
previous reports.1,3,4 PND and TND rates were 9.3% and
8%, respectively. In accordance with other clinical re-
ports,3,4 the presence of acute type A aortic dissection and a
history of cerebral infarction–TIA predicted the occurrence
of postoperative adverse neurologic outcome.
Washiyama and colleagues5 have demonstrated that a
canine brain having a previous cerebral infarction is more
susceptible to ischemia during aortic arch operation by
using ASCP as a consequence of an accelerated anaerobic
metabolism and an increased extracellular glutamate release
in the brain from the previous infarction.
Kazui and colleagues6 recently reported a postoperative
PND rate of 3.3% in a group of 220 patients undergoing
aortic arch replacement with aortic branched grafts and
ASCP. The presence of a previous cerebral infarction was
an independent determinant of PND, with a relative risk of
21.8 on multivariate analysis.
Similarly, a history of cerebrovascular disease has been
TABLE 3. CPB data
Total group,
n (%)
DHCA,
n (%)
ASCP,
n (%) P value
CPB time (min) 198 74 197 54 198 60 .982
Myocardial ischemic time (min) 119 46 105 41 129 48 .001
Total cerebral protection time (min) 35 21 29 9 42 20 .001
Nasopharyngeal temperature (°C) 16.1 2.8 23.2 2.6 .001
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shown to be an independent predictor of postoperative
stroke in aortic arch replacement with DHCA alone.3,4
DHCA with or without retrograde cerebral perfusion and
ASCP are currently being used as methods of brain protec-
tion.
Technical simplicity and avoidance of aorta and arch
vessel manipulation, as well as a bloodless operative field,
make DHCA an attractive method of brain protection, es-
pecially during ascending aorta–hemiarch replacement,
when a short period of circulatory arrest is anticipated.
However, hypothermia-associated coagulopathy7 and pul-
monary, renal, and microembolic complications8 are impor-
tant disadvantages cited in the literature.
ASCP provides several advantages: the circulatory arrest
time can safely be extended up to 90 minutes,1 allowing
more complex aortic repair to be performed, and moderate
(nasopharyngeal temperature 25°C) instead of profound hy-
pothermia can be used with reduced coagulative and sys-
temic complications. Criticism against ASCP includes tech-
nical complexity, reduced surgical visibility, and
manipulation of the aortic arch and arch vessels, especially
in cases of acute dissection or severely atherosclerotic aortic
arch aneurysm.
In the current study we compared DHCA and ASCP in
terms of hospital mortality and neurologic and systemic
morbidity in a group of patients undergoing ascending
aorta–hemiarch replacement.
In our series the patients in the ASCP group had a more
extended aortic tissue replacement and a larger number of
aortic root repairs. Nevertheless, hospital mortality and neu-
rologic outcome were comparable in the 2 groups; reduced
intubation time and better renal function recovery were
noted in the ASCP group.
TND seems to be a manifestation of subtle but diffuse
brain injury associated with long-lasting cognitive impair-
ment undetectable by means of conventional imaging tech-
niques and directly correlated to inadequate brain protec-
tion.9
In our series a circulatory arrest time of greater than 25
minutes was associated with an increased risk of TND in the
DHCA group.
Reich and colleagues10 have demonstrated that a DHCA
time of 25 minutes or greater is associated with memory and
fine motor deficits, as well as with prolonged hospital stays.
McCullough and colleagues11 have recently demonstrated
that the cerebral metabolic rate is still 17% of the baseline
at 15°C and that the safe duration of circulatory arrest at
15°C is only 29 minutes. These findings probably indicate
that circulatory arrest times of 45 to 60 minutes were too
optimistically indicated as safe.4
Surprisingly, no significant differences in terms of retho-
racotomy for bleeding, drain blood loss, and blood products
consumption was observed between the 2 groups. This was
probably because of similar mean CPB times in the 2 groups
or damage of the blood components occurring during per-
fusion through the small ASCP cannulas.
In conclusion, even though this study carries the risks
inherent to the use of retrospective data, some important
conclusions can be reached: (1) the use of DHCA and ASCP
resulted in acceptable results in terms of hospital mortality
and neurologic outcome during ascending aorta–hemiarch
replacement; (2) only preoperative patient characteristics,
such as acute type A aortic dissection, age greater than 70
years, and history of cerebral infarction–TIA, affected hos-
pital mortality and neurologic outcome; (3) in the DHCA
group a circulatory arrest time of more than 25 minutes was
associated with an increased risk of TND; and (4) reduced
TABLE 5. TND patient distribution by DHCA time
DHCA time <25 min DHCA time >25 min P value
TND
Yes 1 (1.9%) 7 (11.9%) .021
No 52 (98.1%) 52 (88.1%)
TABLE 4. DHCA versus ASCP
Total group,
n (%) DHCA, n (%) ASCP, n (%) P value
Hospital mortality 33 (11.4) 17 (13.3) 16 (9.9) .375
PND 27 (9.3) 16 (12.5) 11 (7.6) .075
TND 21 (8.0) 8 (7.1) 13 (8.7) .530
Intubation time (d) 2.9 4.6 3.8 6.3 2.2 2.5 .005
Postoperative creatinine 250 mol/L 16 (5.5) 10 (7.8) 6 (3.7) .030
Postoperative dialysis 5 (1.7) 1 (0.8) 4 (2.5) .270
Postoperative MI 18 (6.2) 7 (5.5) 11 (6.8) .634
Rethoracotomy for bleeding 35 (12.1) 18 (14.1) 17 (10.6) .365
Drain blood production 1524 1090 1542 1242 1509 952 .809
Packed red cells 5.3 4.2 5.4 5.0 5.1 3.5 .529
Blood products consumption 5.7 3.9 5.4 4.0 5.9 3.7 .347
MI, Myocardial infarction.
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postoperative intubation time and better renal function re-
covery were observed in the ASCP group.
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Appendix
Age 70 y
Sex
Acute dissection
Status (elective-urgent)
Ejection fraction
Hypertension
Diabetes
Preoperative renal creatinine level (mol/L)
Preoperative dialysis
History of central neurologic events
Previous cardiovascular surgery by means of median
sternotomy
Extent of replacement (ascending aorta–hemiarch)
Associated procedures (all combined)
Concomitant aortic valve replacement
Concomitant aortic valve–sparing procedures
Concomitant aortic valve suspension
Concomitant Bentall procedure
Concomitant homograft
Concomitant coronary artery bypass grafting
CPB time
CPB time 240 min
Myocardial ischemic time
Myocardial ischemic time 120 min
Selective cerebral perfusion time
Exitus
Postoperative intubation time (d)
Postoperative myocardial infarction
Postoperative creatinine level 250 mol/L
Postoperative hemodialysis
Blood drain production (mL)
Bleeding requiring rethoracotomy
Packed red cells consumption (in units)
Blood products consumption (in units)
Permanent neurologic dysfunction
Transient neurologic dysfunction
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